发明名称 Sustained-release preparation
摘要 <p>Provided is a sustained-release preparation containing pioglitazone or a salt thereof as an active ingredient and showing superior sustainability. A sustained-release preparation containing pioglitazone or a salt thereof, which shows a dissolution ratio of pioglitazone of average 25-58% at the 2-hour time point, and average 60-100% at the 4-hour time point, in a dissolution test according to the 50 rpm USP Paddle Method and using pH 2.0 KCl/HCl buffer at 37° C. as a test solution.</p>
申请公布号 IL232114(D0) 申请公布日期 2014.06.30
申请号 IL20140232114 申请日期 2014.04.13
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人
分类号 A61K 主分类号 A61K
代理机构 代理人
主权项
地址